MedTrace Logo

Markers of Platelet Activation foR Identification of Late Onset Sepsis in Preterm Infants

NCT05530330 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 268

Last updated 2025-07-03

No results posted yet for this study

Summary

The PARENT study will examine platelet and endothelial associated proteins in preterm infants being investigated for late onset sepsis (LOS) to see if infants with fulminant sepsis can be prospectively identified using these markers

Conditions

  • Late-Onset Neonatal Sepsis
  • Necrotising Enterocolitis
  • Culture Negative Neonatal Sepsis

Interventions

DIAGNOSTIC_TEST

Platelet/Endothelial proteomics

Samples taken will undergo a targeted proteomic investigation examining platelet/endothelial markers and associated extracellular vesicles

Sponsors & Collaborators

  • The Rotunda Hospital

    collaborator OTHER

  • National Maternity Hospital, Ireland

    collaborator OTHER

  • Wellcome Trust

    collaborator OTHER

  • Health Research Board, Ireland

    collaborator OTHER

  • University College Dublin

    lead OTHER

Principal Investigators

  • Patricia Maguire · University College Dublin

Eligibility

Max Age
34 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-02
Primary Completion
2025-02-28
Completion
2025-06-27

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05530330 on ClinicalTrials.gov